| Title |
Efficacy of Pirlindole, a Highly Selective Reversible Inhibitor of Monoamine Oxidase Type A, in the Prevention of Experimentally Induced Epileptic Seizures
|
|---|---|
| Published in |
Clinical Drug Investigation, November 2012
|
| DOI | 10.1007/bf03259215 |
| Authors |
A. Medvedev, V. Gorkin, V. Shvedov, O. Fedotova, I. Fedotova, A. Semiokhina |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 1998.
All research outputs
#8,534,976
of 25,374,647 outputs
Outputs from Clinical Drug Investigation
#318
of 1,035 outputs
Outputs of similar age
#67,133
of 201,116 outputs
Outputs of similar age from Clinical Drug Investigation
#30
of 120 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,035 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,116 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.